Literature DB >> 2211433

Faecal excretion of ciprofloxacin after a single oral dose and its effect on faecal bacteria in healthy volunteers.

S Pecquet1, S Ravoire, A Andremont.   

Abstract

High concentrations of ciprofloxacin have been shown to persist in the faeces of volunteers for several days after a week of oral treatment with this drug, which was also found to have a prolonged effect on aerobic Gram-negative intestinal bacteria. To determine whether a shorter course of ciprofloxacin would have the same prolonged effect, we treated ten healthy adult volunteers with a single oral dose of 750 mg ciprofloxacin and found that this was not followed by any significant changes in the counts of anaerobes or streptococci, but that there was a mean decrease of 2.5 log10 cfu/ml in the counts of faecal Enterobacteriaceae, which lasted for a full week. We attributed this to the persistence of high faecal ciprofloxacin concentrations for several days in all the volunteers. We did not observe any significant increase in the MICs of ciprofloxacin for faecal Enterobacteriaceae, or any faecal overgrowth of staphylococci, fungi, Pseudomonas aeruginosa or Clostridium difficile.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2211433     DOI: 10.1093/jac/26.1.125

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Correlation between fecal concentrations of ciprofloxacin and fecal counts of resistant Enterobacteriaceae in piglets treated with ciprofloxacin: toward new means to control the spread of resistance?

Authors:  Thu Thuy Nguyen; Elisabeth Chachaty; Clarisse Huy; Carole Cambier; Jean de Gunzburg; France Mentré; Antoine Andremont
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

2.  Influence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate.

Authors:  W A Krueger; G Ruckdeschel; K Unertl
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  Use of fluoroquinolones is the single most important risk factor for the high bacterial load in patients with nasal and gastrointestinal colonization by multidrug-resistant Acinetobacter baumannii.

Authors:  V C C Cheng; J H K Chen; S Y C So; S C Y Wong; M K Yan; P H Chau; W M Lee; K K W To; J F W Chan; I F N Hung; P L Ho; K Y Yuen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-15       Impact factor: 3.267

4.  Independent behavior of commensal flora for carriage of fluoroquinolone-resistant bacteria in patients at admission.

Authors:  Victoire de Lastours; Françoise Chau; Florence Tubach; Blandine Pasquet; Etienne Ruppé; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

5.  Ciprofloxacin dosage and emergence of resistance in human commensal bacteria.

Authors:  Bruno Fantin; Xavier Duval; Laurent Massias; Loubna Alavoine; Françoise Chau; Sylvie Retout; Antoine Andremont; France Mentré
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

6.  Eradication of convalescent-phase Salmonella carriage in children with two oral doses of pefloxacin.

Authors:  J Raymond; F Moulin; J Badoual; D Gendrel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-04       Impact factor: 3.267

7.  Mathematical modeling of bacterial kinetics to predict the impact of antibiotic colonic exposure and treatment duration on the amount of resistant enterobacteria excreted.

Authors:  Thu Thuy Nguyen; Jeremie Guedj; Elisabeth Chachaty; Jean de Gunzburg; Antoine Andremont; France Mentré
Journal:  PLoS Comput Biol       Date:  2014-09-11       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.